| Sign In to gain access to subscriptions and/or personal tools. |
Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosisDepartment of Neurology, University of Texas Medical School at Houston, Houston, Texas, USA john.w.lindsey{at}uth.tmc.edu
Department of Neurology, University of Texas Medical School at Houston, Houston, Texas, USA
Department of Neurology, University of Texas Medical School at Houston, Houston, Texas, USA
Department of Neurology, University of Texas Medical School at Houston, Houston, Texas, USA Background Epstein–Barr virus (EBV) is associated with MS, but it is not clear whether EBV plays a role in the pathogenesis of MS. Hypothesis We hypothesized that the immune control of EBV might be defective in MS, and that reactivation of EBV might drive the immune response in MS. Methods We collected blood from controls and patients with MS, and measured the amounts of EBV DNA and RNA using quantitative PCR. Results We found that EBV DNA and RNA were frequently detectable in peripheral blood leukocytes from both patients with MS and normal controls. There was no significant difference between patients with MS or controls. Paired samples from a small number of subjects suggest that EBV DNA may increase before and during clinical relapse. Conclusions We conclude that the immune control of EBV infection is similar in MS and controls, and that reactivation of EBV may correlate with MS disease activity.
Key Words: Epstein–Barr virus • multiple sclerosis • quantitative PCR • relapse
This version was published on February
1, 2009 Multiple Sclerosis, Vol. 15, No. 2,
153-158 (2009) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
 |
Sign In to gain access to subscriptions and/or personal tools.
